Wall Street's reaction to Dimon's cancer diagnosis

Wednesday, 2 Jul 2014 | 7:31 AM ET

Paul Miller, FBR Capital Markets discusses whether Dimon's cancer diagnosis will likely impact the stock. And Jeff Sonnenfeld, Yale School of Management, weighs in on other CEOs who had health issues but did not disclose it publicly.